Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
2002
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
PR1 vaccination in myeloid malignancies
2008
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
2007
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
2000
Chronic myeloid leukaemia as a model of disease evolution in human cancer
2007
Immunotherapy of Hematologic Malignancy
2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
2001
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
β-Neurexin Is a Ligand for the Staphylococcus aureus MSCRAMM SdrC
2010 StandoutNobel
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Haematopoietic cell transplantation as immunotherapy
2001 Nature
Allogeneic Offspring Produced by Male Germ Line Stem Cell Transplantation into Infertile Mouse Testis1
2003 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses
2009 StandoutNobel
Graft-versus-host disease
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Molecules and mechanisms of the graft-versus-leukaemia effect
2004
Chronic Myelogenous Leukemia
2002
Hematopoietic Stem-Cell Transplantation
2006 Standout
Molecular remission of chronic myeloid leukaemia following a non‐myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft‐versus‐leukaemia effect
1999
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen
2007
Display technologies: Application for the discovery of drug and gene delivery agents☆
2006
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Engraftment syndrome following hematopoietic stem cell transplantation
2001
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Potential Role for Hyaluronan and the Hyaluronan Receptor RHAMM in Mobilization and Trafficking of Hematopoietic Progenitor Cells
1999
Fludarabine in the treatment of chronic lymphocytic leukemia: a review
2009
Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy
2005
The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score‐matched study
2017
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells
2003
Relations of Inflammatory Biomarkers and Common Genetic Variants With Arterial Stiffness and Wave Reflection
2008
Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia
2002
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia
2008
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
2005
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
2001
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Anastasios Raptis being referenced
High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients
1999
Human G‐CSF‐mobilized CD34‐positive peripheral blood progenitor cells can stimulate allogeneic T‐cell responses: implications for graft rejection in mismatched transplantation
1999
Donor-Recipient Polymorphism of the Proteinase 3 Gene: A Potential Target for T-Cell Alloresponses to Myeloid Leukemia
1999
Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
2004
T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia
1998
Leukapheresis in patients newly diagnosed with acute myeloid leukemia
2016
Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia
2008
Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units
1997
Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units
1997
Disposition of Imatinib and Its Metabolite CGP74588 in a Patient with Chronic Myelogenous Leukemia and Short‐Bowel Syndrome
2006